Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.
Deborah A TheodoreAmrita D HennemanAngela LooRyan K ShieldsGregory EschenauerMagdalena E SobieszczykChristine J KubinPublished in: The Journal of antimicrobial chemotherapy (2024)
These data suggest that among ICU or immunocompromised patients, severity of illness rather than initial antifungal choice drove clinical outcomes.
Keyphrases